MAPT and Schnyder corneal dystrophy: In a memory clinic population, plasma p-tau212 levels were highest in AD dementia and lowest in those with SCD, indicating that phosphorylation at this epitope increases with disease severity, similar to what has been found for other p-tau epitopes8–10.